# First Capital Inc: Form 10-Q for the period ended Sep 30, 2025

- Company: [First Capital Inc](/companies/fcap.md) (CIK 1070296)
- Form: 10-Q
- Filed: 2025-11-14
- Accepted by EDGAR: Nov 14, 2025, 16:32 ET
- Period: 2025-09-30
- Accession: 0001104659-25-112606
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070296/000110465925112606/fcap-20250930x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070296/000110465925112606/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-07-01 to 2025-09-30 | $1.9m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 9 months, 2025-01-01 to 2025-09-30 | $5.3m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Operating income | 3 months, 2025-07-01 to 2025-09-30 | $5.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2025-01-01 to 2025-09-30 | $14.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2025-07-01 to 2025-09-30 | $1.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2025-01-01 to 2025-09-30 | $2.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-07-01 to 2025-09-30 | $4.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2025-01-01 to 2025-09-30 | $11.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-07-01 to 2025-09-30 | $1.34 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2025-01-01 to 2025-09-30 | $3.43 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-07-01 to 2025-09-30 | $1.34 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2025-01-01 to 2025-09-30 | $3.43 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-07-01 to 2025-09-30 | 3,350,008,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2025-01-01 to 2025-09-30 | 3,349,321,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2025-01-01 to 2025-09-30 | $16.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2025-01-01 to 2025-09-30 | $654.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2025-01-01 to 2025-09-30 | $3.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2025-01-01 to 2025-09-30 | $61.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | at 2025-09-30 | $1.24bn | us-gaap:Assets |
| Total liabilities | at 2025-09-30 | $1.10bn | us-gaap:Liabilities |
| Short-term borrowings | at 2025-09-30 | $0 | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2025-09-30 | $132.4m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 1,412 characters.

| ​ ​ ​ ​ ​ Period ​ | ​ ​ ​ ​ ​ ​ | ​ ​ ​ ​ (a) Total Number of Shares Purchased ​ | ​ ​ ​ ​ ​ ​ | ​ ​ ​ ​ ​ (b) Average Price Paid Per Share ​ ​ | ​ ​ ​ ​ ​ ​ | ​ (c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs ​ | ​ ​ ​ ​ ​ ​ | ​ (d) Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs ​ |
| --- | --- | ---: | --- | --- | --- | ---: | --- | ---: |
| July 1 through July 31, 2025 |  | 235 |  | $43.76 |  | 235 |  | 113,236 |
| ​ | ​ | ​ | ​ | ​ ​ | ​ | ​ | ​ | ​ |
| August 1 through August 31, 2025 |  | — | ​ | ​ N/A |  | — |  | 113,236 |
| ​ | ​ | ​ | ​ | ​ ​ | ​ | ​ | ​ | ​ |
| September 1 through September 30, 2025 |  | 1,208 | ​ | ​ 43.50 |  | 1,208 |  | 112,028 |
| ​ | ​ | ​ | ​ | ​ ​ | ​ | ​ | ​ | ​ |
| Total |  | 1,443 | ​ | $43.55 |  | 1,443 |  |  |

On August 29, 2025, the Company entered into a Joint Rule 10b5-1/Rule 10b-18 Plan Agreement (the “Plan”) under which the Company’s designated broker has the authority to repurchase up to 113,236 shares of common stock of the Company. The Plan commenced on September 4, 2025, and expires on August 28, 2026. The Plan was established in connection with the Company’s previously disclosed stock repurchase authorization, which was approved by the Company’s Board of Directors on August 19, 2008. The purchases disclosed in the table above were made pursuant to the terms of the Plan.

## Risk factors

As filed, 422 characters.

There have been no material changes to the risk factors previously disclosed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

Recent changes in international trade regulation or foreign trade policy, including tariffs, could lead to higher than anticipated inflation and supply chain disruption, which may impact consumer and commercial borrower performance.

Filed Nov 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-112606. Last ingested by Listed: Nov 6, 2026, 18:07 ET. No prices; not investment advice.